Parkinson's disease medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:
==Medical Therapy==
==Medical Therapy==
The mainstay of therapy for motor symptoms of Parkinson disease are:  
The mainstay of therapy for motor symptoms of Parkinson disease are:  
* Levodopa:
* Levodopa: This drug is the most effective in controlling motor symptoms in [[Parkinson's disease|PD]] patients (2_8). If we use [[levodopa]] alone, it will convert to [[dopamine]] in the peripheral circulation, so we combine it with a decarboxylase inhibitor like [[carbidopa]] to prevent this. The ratio of carbidopa_levodopa in tablets are 10/100, 25/100 or 25/250.(9_10) The [[adverse effects]] of this drug includes elevated serum [[homocysteine]], low levels of [[vitamin B12]], elevated [[methylmalonic acid]] and sensorimotor peripheral neuropathy.(17 ta 20) It can also cause motor fluctuations, [[dyskinesia]], [[cramps]] and [[dystonia]].(21_22) One of the concerns regarding long term use of [[levodopa]] is that it may be increase the rate of [[dopamine]] [[Neuron|neurons]] degeneration(37) but other studies demonstrated  that it does not damage [[Neuron|neurons]].(39_40)


* Dopamine agonists:
* Dopamine agonists:

Revision as of 07:39, 20 April 2018

Parkinson's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Parkinson's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Neurocognitive Disorder Due to Parkinson's Disease

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Parkinson's disease medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Parkinson's disease medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Parkinson's disease medical therapy

CDC on Parkinson's disease medical therapy

Parkinson's disease medical therapy in the news

Blogs on Parkinson's disease medical therapy

Directions to Hospitals Treating Parkinson's disease

Risk calculators and risk factors for Parkinson's disease medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medical Therapy

The mainstay of therapy for motor symptoms of Parkinson disease are:

  • Levodopa: This drug is the most effective in controlling motor symptoms in PD patients (2_8). If we use levodopa alone, it will convert to dopamine in the peripheral circulation, so we combine it with a decarboxylase inhibitor like carbidopa to prevent this. The ratio of carbidopa_levodopa in tablets are 10/100, 25/100 or 25/250.(9_10) The adverse effects of this drug includes elevated serum homocysteine, low levels of vitamin B12, elevated methylmalonic acid and sensorimotor peripheral neuropathy.(17 ta 20) It can also cause motor fluctuations, dyskinesia, cramps and dystonia.(21_22) One of the concerns regarding long term use of levodopa is that it may be increase the rate of dopamine neurons degeneration(37) but other studies demonstrated  that it does not damage neurons.(39_40)
  • Dopamine agonists:
  • Monoamine oxidase (MAO) B inhibitors:
  • Anticholinergic agents:
  • Amantadine:
  • Catechol-O-methyl transferase (COMT) inhibitors:
  • Estrogen:
  • Other agents:

Treatment choices for some of the nonmotor symptoms of PD are:

  • Psychosis:
  • Dementia:
  • Daytime sleepiness:
  • Fatigue:
  • Depression:
  • Constipation:
  • Sialorrhea:
  • Rhinorrhea:
  • Sexual dysfunction:
  • Ortostatic hypotention:

References

Template:WH Template:WS